Pharma positions itself for 2026 amid an evolving US landscape
From tariffs and onshoring to MFN, the US has seen significant policy developments - but how will these impact pharma in 2026?
23 December 2025
23 December 2025
From tariffs and onshoring to MFN, the US has seen significant policy developments - but how will these impact pharma in 2026?
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.